Ariana Pelosci

Assistant Managing Editor @cancernetwrk | University of Delaware ‘21 | Author of Roxy and Velvet’s Big Adventure

[Ariana Pelosci @APelosci]

@CancerNetwrk Excited to finally launch our special anniversary issue with the help from our co-EICs @DrJulieVose and @Neil_Iyengar

[Gina Mauro @ginacolumbusonc]

Great time in the Big Apple with some of our @OncLive and @CancerNetwrk crew at @gotoPER #NYGU today. Awesome work! 🙌🏻

[Ariana Pelosci @APelosci]

It was great speaking with Dr. Taplin today during #NYGU! Excited to see CancerNetwork’s Women in Oncology program come together.

[CancerNetwork® @CancerNetwrk]

It was a happy #InternationalWomensDay — we sat down with Dr Mary-Ellen Taplin of @DanaFarber to discuss her career in GU oncology! Keep your eye out for a brand new #womeninonc program 👀 #NYGU @gotoPER @APelosci #pcsm

[Ariana Pelosci @APelosci]

It was great speaking with Dr. Gong about the upcoming @myESMO meeting. He gave a great overview on upcoming presentations, and which will be most impactful in the bladder and gastrointestinal space.

[Jun Gong @jgong15]

Thank you @CancerNetwrk @APelosci! Always a pleasure catching up on latest GI/GU cancer breakthroughs especially with an exciting @myESMO 2023 fast approaching @CSCancerCenter @CedarsSinaiMed @CedarsSinai

[Ariana Pelosci @APelosci]

“The number one thing is to give each other grace,” said @NarjustFlorezMD during my interview with her on physician burnout. Her advice on grace and setting boundaries in a workplace setting is something I have held on to since we spoke. https://t.co/ZJ2qTk3dcW

[Ariana Pelosci @APelosci]

With cisplatin shortages occurring across the US, @KirollosPharmD and @DrDanaChase discuss how it is affecting treatment options in bladder and gynecological cancers.

[CancerNetwork® @CancerNetwrk]

In February 2023, the FDA announced a shortage of carboplatin and cisplatin. These shortages have negatively impacted every disease state, including gynecologic and genitourinary cancer. #gyncsm | @DrDanaChase @KirollosPharmD

https://t.co/8FBMlq24tS

[Ariana Pelosci @APelosci]

Excited to work with @Rfonsi1 and @DrKrinaPatel to discuss recent updates in hematology from #ASCO23!

[CancerNetwork® @CancerNetwrk]

Join CancerNetwork and co-hosts @Rfonsi1 and @DrKrinaPatel to discuss practice updates in the hematology space from #ASCO23. @ASCO @MDAndersonNews @MayoClinic

https://t.co/GlGsFjogJt

[CancerNetwork® @CancerNetwrk]

Interested in submiting your research to a peer-reviewed, PubMed-index journal? View ONCOLOGY's submission guidelines to see where your manuscript would fit best.

https://t.co/n8eAQINJ6R

[Ariana Pelosci @APelosci]

New data out of @ASCO regarding zanidatamab use in pancreatic cancer. #ASCO23 #pancsm

[CancerNetwork® @CancerNetwrk]

The use of zanidatamab yielded improved efficacy responses in patients with HER2-amplified, locally advanced, unresectable or metastatic biliary tract cancer who received prior gemcitabine therapy. #gicsm #ASCO23 | @ASCO @DrShubhamPant

https://t.co/9E1TllL6NM

[Ariana Pelosci @APelosci]

It was great speaking with @Ashley_Rosko1 regarding the current multiple myeloma treatment landscape.

[CancerNetwork® @CancerNetwrk]

.@Ashley_Rosko1 reviews the current treatment landscape of multiple myeloma, and how tailoring treatment options should be an important focus for clinicians. #mmsm | @OSUCCC_James

https://t.co/wUQ1s6AmnY

[CancerNetwork® @CancerNetwrk]

Interested in the latest cancer coverage that includes peer-reviewed studies on multiple myeloma or gastrointestinal cancer? Our April issue of ONCOLOGY is ready for download now!

https://t.co/SHt0fXTMTj

[Ariana Pelosci @APelosci]

So excited to be working with these two incredible doctors to discuss breaking presentations from @SGO_org

[CancerNetwork® @CancerNetwrk]

On April 3rd at 2 pm ET, @RSalaniMD and @DrDanaChase from @UCLAHealth will discuss recent data from @SGO_org in a live Twitter Spaces!

[CancerNetwork® @CancerNetwrk]

During a live Tweet Chat, Hope S. Rugo, MD, and Paolo Tarantino, MD, reviewed a patient case and discussed current standard of care for those with metastatic triple-negative breast cancer. #bcsm | @hoperugo @PTarantinoMD

https://t.co/EmCha6iZYt

[Ariana Pelosci @APelosci]

Excited to be working with @KalinskyKevin and @jane_meisel of @WinshipAtEmory to discuss the recent approval of sacituzumab govitecan

[CancerNetwork® @CancerNetwrk]

Tune in Wednesday 2/8 at 10:30 am ET for a Twitter Spaces with Kevin Kalinsky, MD, MS, and Jane Lowe Meisel, MD, to discuss the recent approval of sacitizumab govitiecan. #bcsm | @KalinskyKevin @jane_meisel @WinshipAtEmory

[Ariana Pelosci @APelosci]

Breaking from @US_FDA sacituzumab govitecan approved in pre-treated HR+/HER- #bcsm

[CancerNetwork® @CancerNetwrk]

Patients with pre-treated, unresectable locally advanced or metastatic hormone receptor-positive, HER2-negative breast cancer can now receive treatment with sacituzumab govitecan following approval from the FDA. #bcsm | @US_FDA @FDAOncology

https://t.co/ZXIsHJUA1q

[Ariana Pelosci @APelosci]

@US_FDA recently updated the labeling of oral capecitabine across various cancer types. Rowena Schwartz, PharmD, BCOP, of @UCPharmacy discussed how this can impact current clinical practice.

[CancerNetwork® @CancerNetwrk]

Under a new FDA initiative, the agency recently updated a decades’ old approval of the chemotherapy capecitabine. This move, according to an expert, will springboard further change in the treatment of cancer. @US_FDA @UCPharmacy

https://t.co/ix2BoUtzNK

[Ariana Pelosci @APelosci]

Excited to be working with @PTarantinoMD and @hoperugo on this new initiative discussing treatment updates in TNBC

[CancerNetwork® @CancerNetwrk]

Join us on Thursday, January 26th at 7 pm ET with @PTarantinoMD and @hoperugo to discuss current treatments in triple-negative breast cancer.

[Sahil Bloom @SahilBloom]

Today is my 32nd birthday.

Over the last month, I asked several 90-year-olds what advice they would give to their 32-year-old selves.

Here's the life advice everyone needs to hear:

[CancerNetwork® @CancerNetwrk]

The team at CancerNetwork wishes everyone a very happy holidays!

[Ariana Pelosci @APelosci]

Happening soon! Don’t miss out on the live takeover happening during @SABCSSanAntonio with @Neil_Iyengar!

[CancerNetwork® @CancerNetwrk]

Join us today with Neil M. Iyengar, MD, as he takes over our Twitter to discuss the general session during @SABCSSanAntonio. Which presentations are you most looking forward to? #CNRealtimeReport #SABCS2022 | @Neil_Iyengar @MSKCancerCenter